Oftalmología

2024

1. Anti-retinal Antibodies in Sarcoidosis

   Ocular Immunology and Inflammation, Vol. 32, Núm. 2, pp. 141-147

2. Assessing the economic burden of vision loss and irreversible legal blindness in Spain (2021–2030): a societal perspective

   Health Economics Review, Vol. 14, Núm. 1

3. Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease

   npj Parkinson's Disease, Vol. 10, Núm. 1

4. Author Correction: Effectiveness and safety of XEN63 in patients with primary-open-angle glaucoma (Scientific Reports, (2024), 14, 1, (4561), 10.1038/s41598-024-55287-z)

   Scientific Reports

5. Author Reply to Letter to the Editor: In Response to: Comment on Fonollosa et al.‘s “Hyper-Reflective Outer Nuclear Layer (HONL) in Vogt-Koyanagi-Harada Disease and Sympathetic Ophthalmia”

   Ocular Immunology and Inflammation

6. C-reactive protein-complement factor H axis as a biomarker of activity in early and intermediate age-related macular degeneration

   Frontiers in Immunology, Vol. 15

7. Características del desprendimiento de retina pseudofáquico y factores de riesgo de recidiva

   Archivos de la Sociedad Española de Oftalmologia, Vol. 99, Núm. 9, pp. 365-372

8. Childhood-Onset Non-Infectious Uveitis in the “Biologic Era”. Results From Spanish Multicenter Multidisciplinary Real-World Clinical Settings

   Ocular Immunology and Inflammation

9. Colour perception develops throughout childhood with increased risk of deficiencies in children born prematurely

   Acta Paediatrica, International Journal of Paediatrics, Vol. 113, Núm. 2, pp. 259-266

10. Comparison between a new transepithelial PRK vs. conventional alcohol-assisted PRK: Corneal densitometry and aberrometry study

    European Journal of Ophthalmology

11. Corneal abscess caused by Filobasidium uniguttulatum. Case report and literature review on cryptococcal keratitis

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

12. Corrigendum: Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries (Front. Med., 11, (1439338), (10.3389/fmed.2024.1439338))

    Frontiers in Medicine

13. Dry eye disease and spondyloarthritis: expanding the spectrum of systemic inflammatory disorders associated with ocular surface disease. Data from the international AIDA Network Spondyloarthritis Registry

    Frontiers in Medicine, Vol. 11

14. Effectiveness and Safety of Biosimilars in Pediatric Non-infectious Uveitis: Real-Life Data from the International AIDA Network Uveitis Registry

    Ophthalmology and Therapy, Vol. 13, Núm. 3, pp. 761-774

15. Effectiveness and safety of XEN63 in patients with primary-open-angle glaucoma

    Scientific Reports, Vol. 14, Núm. 1

16. Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries

    Frontiers in Medicine, Vol. 11

17. Fight Retinal Blindness SPAIN. Report 3: clinical outcomes of vascular endothelial growth factor inhibitors in low vision eyes with neovascular age-related macular degeneration. A national database study

    Eye (Basingstoke)

18. Fluocinolone intravitreal implant (Iluvien) for macular edema secondary to immune recovery uveitis in patient with acute myeloid leukemia

    Journal of Ophthalmic Inflammation and Infection, Vol. 14, Núm. 1

19. Hyper-Reflective Outer Nuclear Layer (HONL) in Vogt–Koyanagi–Harada Disease and Sympathetic Ophthalmia

    Ocular Immunology and Inflammation, Vol. 32, Núm. 4, pp. 419-423

20. Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders

    Ocular Immunology and Inflammation